Harel Insurance Investments & Financial Services’s Cellebrite CLBT Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,693	Closed	-$20K	–	505
2024 Q2	$20K	Sell	1,693 -1,063	-39%	-$11.9K	﹤0.01%	441
2024 Q1	$31K	Sell	2,756 -513	-16%	-$5.24K	﹤0.01%	412
2023 Q4	$28K	Sell	3,269 -911	-22%	-$7.08K	﹤0.01%	481
2023 Q3	$32K	Sell	4,180 -937	-18%	-$7.03K	﹤0.01%	506
2023 Q2	$37K	Sell	5,117 -2,858	-36%	-$16.7K	﹤0.01%	514
2023 Q1	$49K	Buy	7,975 +2,523	+46%	+$13.7K	﹤0.01%	486
2022 Q4	$24K	Sell	5,452 -551	-9%	-$2.46K	﹤0.01%	555
2022 Q3	$24K	Buy	6,003 +2,083	+53%	+$10.4K	﹤0.01%	577
2022 Q2	$20K	Buy	+3,920	New	+$20.4K	﹤0.01%	631
2022 Q1	–	Sell	-4,459	Closed	-$35K	–	723
2021 Q4	$35K	Buy	+4,459	New	+$42K	﹤0.01%	637

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Harel Insurance Investments & Financial Services's CLBT Position: Q3 2024 in Review

Harel Insurance Investments & Financial Services sold out of Cellebrite (CLBT) in Q3 2024, closing a stake of 1,693 shares — an estimated $20K sold.

Harel Insurance Investments & Financial Services first reported a position in CLBT in Q4 2021 and held it in 10 quarters. The position peaked at $49K in Q1 2023. 164 funds tracked by Wall St. Rank hold CLBT as of Q3 2024.

Harel Insurance Investments & Financial Services reported no remaining Cellebrite position as of Q3 2024 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 1,693 Cellebrite shares in Q3 2024, an estimated $20K.
Harel Insurance Investments & Financial Services first reported a position in Cellebrite in Q4 2021 and held it in 10 quarters.
Harel Insurance Investments & Financial Services's Cellebrite position peaked at $49K in Q1 2023.
164 funds tracked by Wall St. Rank held Cellebrite as of Q3 2024.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2024, filed 15 Oct 2024.